Met Life Investment Management, LLC Olema Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 23,695 shares of OLMA stock, worth $97,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,695
Previous 23,695
-0.0%
Holding current value
$97,623
Previous $282,000
51.06%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OLMA
# of Institutions
161Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$30.8 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$30.1 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$23.5 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$16.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$15.1 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $167M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...